DENTSPLY SIRONA Inc.
No SEC Form 4 filings for $XRAY in the last 30 days.
See all $XRAY insider activity →Henry Schein (HSIC) reported Q2 revenues of $3.46B, up 6.7% YoY, beating estimates. Envista (NVST) saw 7.1% YoY growth, while Align Tech (ALGN) and Dentsply Sirona (XRAY) reported mixed results. Sector stocks are down 18.3% on average since earnings.
Dentsply Sirona (XRAY) expanded its U.S. distribution agreement with Midwest Dental Equipment & Supply, effective Nov. 1, 2026. The deal aims to boost sales of its digital dentistry products. XRAY stock rose 3.6% post-announcement, though it's down 22.8% year-to-date. The company's market cap is $1.76B. The global digital dentistry market is projected to grow at a 9.3% CAGR through 2034, according to Fortune Business Insights.
Dentsply Sirona (XRAY) amended its revolving credit facility and private notes to ease covenants and adjust pricing. The changes include raising leverage ratios, permitting EBITDA addbacks, and temporarily restricting certain payments. Management aims to maintain compliance and liquidity while advancing cost initiatives.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning XRAY (DENTSPLY SIRONA Inc.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.
Recent XRAY coverage spans earnings, financial news and corporate actions.
No new catalyst; stock down over 34% since the earnings release.
The new partnership broadens market reach for XRAY's digital dentistry portfolio.
Dentsply Sirona (XRAY) amended its revolving credit facility and private notes to ease covenants and adjust pricing. The changes include raising leverage ratios, permitting EBITDA addbacks, and temporarily restricting certain payments. Management aims to maintain compliance and liquidity while advancing cost initiatives.
The amendment gives the company more borrowing capacity but also introduces higher interest if leverage thresholds are breached, which may weigh on the stock.
Piper Sandler kept a Neutral rating on Dentsply Sirona (XRAY) with a $12 price target, implying a 38.1% upside from the Oct 8 close. The firm cited weak growth projections and reduced its target from $14 due to a more conservative outlook.
AlphAI scores every news story that mentions XRAY with an AI model for sentiment and relevance, and aggregates insider trades from DENTSPLY SIRONA Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Henry Schein (HSIC) reported Q2 revenues of $3.46B, up 6.7% YoY, beating estimates. Envista (NVST) saw 7.1% YoY growth, while Align Tech (ALGN) and Dentsply Sirona (XRAY) reported mixed results. Sector stocks are down 18.3% on average since earnings.
3 min readDentsply Sirona (XRAY) expanded its U.S. distribution agreement with Midwest Dental Equipment & Supply, effective Nov. 1, 2026. The deal aims to boost sales of its digital dentistry products. XRAY stock rose 3.6% post-announcement, though it's down 22.8% year-to-date. The company's market cap is $1.76B. The global digital dentistry market is projected to grow at a 9.3% CAGR through 2034, according to Fortune Business Insights.
2 min readDentsply Sirona (XRAY) amended its revolving credit facility and private notes to ease covenants and adjust pricing. The changes include raising leverage ratios, permitting EBITDA addbacks, and temporarily restricting certain payments. Management aims to maintain compliance and liquidity while advancing cost initiatives.
2 min readDENTSPLY SIRONA Inc. (XRAY) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry Into a Material Definitive Agreement On October 8, 2026, DENTSPLY SIRONA Inc. (the “Company”) obtained the consent of the requisite lenders under its revolving credit facility, dated May 12, 2023, with JPMorgan Chase Bank, N.A., as administrative agent, to, among
2 min readPiper Sandler kept a Neutral rating on Dentsply Sirona (XRAY) with a $12 price target, implying a 38.1% upside from the Oct 8 close. The firm cited weak growth projections and reduced its target from $14 due to a more conservative outlook.
1 min readDENTSPLY SIRONA (XRAY) expanded its partnership with Midwest Dental, starting November 2026, to distribute its technology portfolio across the U.S. This move aims to increase the reach of its digital dentistry tools. The company has updated seven North American dealer relationships in 2026, seeking broader coverage. Despite this, XRAY's stock has declined 20.93% over 30 days and 27.86% over one year.
6 min readDentsply Sirona (XRAY) expanded its partnership with Midwest Dental, adding its technology portfolio to the distributor's offerings. Effective November 1, 2026, Midwest Dental will provide Dentsply Sirona's digital dentistry solutions, enhancing access for dental professionals. This is the seventh such deal for Dentsply Sirona in 2026, supporting its strategy to broaden customer access and market coverage.
1 min readEnvista, Henry Schein, Align Technology, and Dentsply Sirona reported Q2 earnings. Henry Schein beat revenue and EPS estimates, while Align met revenue expectations but missed guidance. Dentsply Sirona's revenue declined but topped estimates. Stocks reacted negatively post-earnings, with Align down 20.1% and Dentsply down 30.6%.
2 min readEnvista (NYSE:NVST) reported Q2 revenue of $730.5M, up 7.1% YoY, beating estimates. Align Technology (NASDAQ:ALGN) reported $1.06B, up 4.3% YoY, missing revenue guidance. Henry Schein (NASDAQ:HSIC) reported $3.46B, up 6.7% YoY, beating estimates. Stocks are down since reporting.
3 min readDentsply Sirona reported a Q2 2026 profit of $37M, reversing a $45M loss from the prior year, despite a 4.1% sales decline to $898M. Gross margin improved to 54.9%, and operating cash flow doubled to $99M. The company's turnaround plan aims for $120M in annual savings. Management maintained its full-year outlook.
2 min read
